UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053583
Receipt number R000061144
Scientific Title Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts
Date of disclosure of the study information 2024/03/01
Last modified on 2024/02/13 16:58:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts

Acronym

Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts

Scientific Title

Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts

Scientific Title:Acronym

Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts

Region

Japan


Condition

Condition

Healthy population

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study of Inhibition of Salt Absorption in Foods Containing Plant Derived Extracts

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in urinary sodium

Key secondary outcomes

Changes in blood sodium


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Plant-derived extracts

Interventions/Control_2

Placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

(1) Japanese males between the ages of 20 and 60 years at the time of consent
(2) BMI between 18.5 kg/m2 and 25.0 kg/m2 at screening
(3) Systolic blood pressure less than 160 mmHg and diastolic blood pressure less than 100 mmHg at screening
(4) Those who agree to participate in the study and are able to sign and date the consent form themselves

Key exclusion criteria

(1) Participants with a history of serious medical history or surgical resection of the digestive tract (excluding appendicectomy and endoscopic polypectomy)
(2) Participants with diseases affecting excretion, digestion and absorption, or those who are aware of various symptoms of indigestion, constipation, diarrhea, etc. on a daily basis
(3) Participants with a history of treatment for pre-existing abnormalities in renal function, liver function, blood pressure level, glucose or lipid metabolism
(4) Participants who are taking oral drugs or supplements on a regular basis
(5) Heavy alcohol drinkers (>60g of pure alcohol/day) and excessive smokers (>20 cigarettes/day) (including those who are unable to quit smoking during the clinic visit time frame or those who are unable to maintain mental and physical health by quitting smoking)
(6) Participants who are participating or will participate in an interventional trial involving the intake of other foods or drugs, or the application of cosmetics or quasi-drugs.
(7) Participants who work late at night (22:00-5:00) or work overtime for a long period of time.
(8) Participants who have donated 400 mL of blood within 6 months prior to this study.
(9) Participants who have food allergies or dislike foods, including the test food and the standardized meal.
(10) Participants who may not be able to consume ingredients whose origin is not specified in the test food due to religious or other reasons.
(11) Participants who are otherwise judged by the investigator to be inappropriate to participate in this study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name masaya
Middle name
Last name tsubokawa

Organization

FANCL Research Institute

Division name

clinical trial group

Zip code

2440806

Address

12-13 Shinano, Totsuka-ku, Yokohama, Kanagawa Prefecture

TEL

045-820-3659

Email

tsubokawa_masaya@fancl.co.jp


Public contact

Name of contact person

1st name masaya
Middle name
Last name tsubokawa

Organization

FANCL Research Institute

Division name

clinical trial group

Zip code

2440806

Address

12-13 Shinano, Totsuka-ku, Yokohama, Kanagawa Prefecture

TEL

045-820-3659

Homepage URL


Email

tsubokawa_masaya@fancl.co.jp


Sponsor or person

Institute

other

Institute

Department

Personal name



Funding Source

Organization

other

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamazaki Otorhinolaryngology Clinic Ethics Review Committee

Address

Kita 11-jo Nishi 14-1-16, Chuo-ku, Sapporo, Hokkaido

Tel

011-757-3387

Email

i-takehara@kyowa-t.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 02 Month 06 Day

Date of IRB

2024 Year 02 Month 06 Day

Anticipated trial start date

2024 Year 03 Month 01 Day

Last follow-up date

2024 Year 04 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 09 Day

Last modified on

2024 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061144


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name